SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-16-012444
Filing Date
2016-04-22
Accepted
2016-04-22 08:06:53
Documents
6
Period of Report
2016-05-26
Effectiveness Date
2016-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2228369zdef14a.htm DEF 14A 399133
2 G24212BKI001.GIF g24212bki001.gif GRAPHIC 96971
3 G24212BKI002.GIF g24212bki002.gif GRAPHIC 78784
4 G427526.JPG g427526.jpg GRAPHIC 11748
5 G5970.JPG g5970.jpg GRAPHIC 9084
6 G443112.JPG g443112.jpg GRAPHIC 6659
  Complete submission text file 0001047469-16-012444.txt   680892
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37350 | Film No.: 161585320
SIC: 3841 Surgical & Medical Instruments & Apparatus